The activity of thiosemicarbazones alone and in combination with other drugs in experimental corneal tuberculosis

PMCID: PMC1509186 PMID: 14821305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

HURNI H. Die tuberkulostatische Wirkung von Kombinationen einiger bekannter Chemotherapeutica. Schweiz Z Pathol Bakteriol. 1949;12(5):596–601. [PubMed] [Google Scholar]
MERTENS A., BUNGE R. The present status of the chemotherapy of tuberculosis with conteben a substance of the thiosemicarbazone series; a review. Am Rev Tuberc. 1950 Jan;61(1):20–38. doi: 10.1164/art.1950.61.1.20. [DOI] [PubMed] [Google Scholar]
REES R. J. W., ROBSON J. M. Experimental tuberculous infections of the cornea of the mouse; a screening test for anti-tuberculous substances. Br J Pharmacol Chemother. 1950 Mar;5(1):77–86. doi: 10.1111/j.1476-5381.1950.tb00579.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
SIMMONS G., HOBSON L. B., RESNICK A., DeNICOLA R., BENNETT R. H. Human pharmacology of p-formylacetanilide thiosemicarbazone (myvizone). Am Rev Tuberc. 1950 Aug;62(2):128–143. doi: 10.1164/art.1950.62.2.128. [DOI] [PubMed] [Google Scholar]
ULSTRUP J. C. Treatment of experimental tuberculosis of guinea pigs by a combination of PAS and TB-I 698. Acta Pathol Microbiol Scand. 1950;27(4):487–491. [PubMed] [Google Scholar]